Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 285 publications
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.
Journal: Nature
Published: July 01, 2026
LRRC8A as a candidate biomarker of cisplatin sensitivity in muscle-invasive bladder cancer: an exploratory immunohistochemical study.
Journal: International urology and nephrology
Published: June 26, 2026
Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers.
Journal: NPJ precision oncology
Published: February 13, 2026
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics.
Journal: Clinical genetics
Published: December 18, 2025
The WHO Classification of Genetic Tumour Syndromes: Considerations for histopathology.
Journal: Histopathology
Published: December 18, 2025
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2025
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2025
Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate Cancer.
Journal: Cancer research
Published: November 25, 2025
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules.
Journal: bioRxiv : the preprint server for biology
Published: September 15, 2025
Last Updated: 09/26/2026